{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:55:19Z","timestamp":1791262519596,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT25Z2710"],"award-info":[{"award-number":["DUT25Z2710"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT24YG153"],"award-info":[{"award-number":["DUT24YG153"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT25YG250"],"award-info":[{"award-number":["DUT25YG250"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273778"],"award-info":[{"award-number":["82273778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270186"],"award-info":[{"award-number":["82270186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002980","name":"Dalian University of Technology","doi-asserted-by":"publisher","award":["LD2023036"],"award-info":[{"award-number":["LD2023036"]}],"id":[{"id":"10.13039\/501100002980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110488","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:09:51Z","timestamp":1788995391000},"page":"110488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-guided design of a GSH-activated Hsp70 targeting prodrug with enhanced tumor selectivity"],"prefix":"10.1016","volume":"182","author":[{"given":"Qimeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangkui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Lun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110488_bb0005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","article-title":"The Hsp70 chaperone network","volume":"20","author":"Rosenzweig","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110488_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110492","article-title":"The multifunction of HSP70 in cancer: guardian or traitor to the survival of tumor cells and the next potential therapeutic target","volume":"122","author":"Sha","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.110488_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040601","article-title":"HSP70 family in Cancer: signaling mechanisms and therapeutic advances","volume":"13","author":"Zhao","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.110488_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat shock proteins and Cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.110488_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00280-009-1194-3","article-title":"A novel, small molecule inhibitor of Hsc70\/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells","volume":"66","author":"Massey","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110488_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081500","article-title":"Heat shock proteins, a double-edged sword: significance in cancer progression, chemotherapy resistance and novel therapeutic perspectives","volume":"16","author":"Kunachowicz","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110488_bb0035","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1002\/ange.200802801","article-title":"An apoptosis-inducing small molecule that binds to heat shock protein 70","volume":"120","author":"Williams","year":"2008","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.chembiol.2014.11.007","article-title":"The novolactone natural product disrupts the allosteric regulation of Hsp70","volume":"22","author":"Hassan","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110488_bb0045","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/cb500236y","article-title":"Structural basis for the inhibition of HSP70 and DnaK chaperones by small-molecule targeting of a C-terminal allosteric pocket","volume":"9","author":"Leu","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110488_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00001813-199903000-00010","article-title":"Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units","volume":"10","author":"Petit","year":"1999","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bioorg.2026.110488_bb0055","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/ml400204n","article-title":"Analogues of the allosteric heat shock protein 70 (Hsp70) inhibitor, MKT-077, as anti-cancer agents","volume":"4","author":"Li","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110488_bb0060","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1021\/acs.jmedchem.8b00583","article-title":"Exploration of benzothiazole rhodacyanines as allosteric inhibitors of protein-protein interactions with heat shock protein 70 (Hsp70)","volume":"61","author":"Shao","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0065","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1021\/acs.jmedchem.3c01783","article-title":"Exploiting the \u201chot-spots\u201d of Hsp70-Bim protein-protein interaction to optimize the 1-Oxo-1H-phenalene-2,3-dicarbonitrile analogues as specific Hsp70-Bim inhibitors","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41419-017-0160-y","article-title":"Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models","volume":"9","author":"Lazarev","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110488_bb0075","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1021\/acs.jmedchem.0c02091","article-title":"Function, therapeutic potential, and inhibition of Hsp70 chaperones","volume":"64","author":"Ambrose","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0080","doi-asserted-by":"crossref","first-page":"12068","DOI":"10.1021\/acs.jmedchem.4c00780","article-title":"Discovery of biphenyl derivatives to target Hsp70-Bim protein-protein interaction in chronic myeloid leukemia by scaffold hopping strategy","volume":"67","author":"Jiang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110488_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2026.110488_bb0095","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110488_bb0100","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1002\/ange.201311133","article-title":"An activatable theranostic for targeted cancer therapy and imaging","volume":"126","author":"Bhuniya","year":"2014","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0105","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1002\/ange.201403221","article-title":"Selective ablation of \u03b2-galactosidase-expressing cells with a rationally designed activatable photosensitizer","volume":"126","author":"Ichikawa","year":"2014","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0110","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1039\/D2CS00673A","article-title":"The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy","volume":"52","author":"Han","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.110488_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41573-024-00914-7","article-title":"The landscape of small-molecule prodrugs","volume":"23","author":"Fralish","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110488_bb0120","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/molecules25040884","article-title":"Newly developed prodrugs and prodrugs in development; an insight of the recent years","volume":"25","author":"Najjar","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110488_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113746","article-title":"Glutathione-responsive prodrug conjugates for image-guided combination in cancer therapy","volume":"225","author":"Ye","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0130","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.cclet.2022.03.040","article-title":"A glutathione activatable pro-drug-photosensitizer for combined chemotherapy and photodynamic therapy","volume":"33","author":"Yang","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110488_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106793","article-title":"Selective degradation of BRD4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors","volume":"140","author":"Fan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0140","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1039\/D4CC06634K","article-title":"Cancer-specific dual-factor cascade recognition fluorescent probe for imaging and tumor diagnosis","volume":"61","author":"Wang","year":"2025","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.110488_bb0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/molecules25051149","article-title":"Reactive oxygen species (ROS)-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib","volume":"25","author":"Bielec","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110488_bb0150","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/jm2014937","article-title":"Aminoferrocene-based prodrugs activated by reactive oxygen species","volume":"55","author":"Hagen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2022.122305","article-title":"4-Ferrocenylaniline-based ROS-responsive prodrugs with anticancer activity","volume":"964","author":"Xu","year":"2022","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110488_bb0160","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1039\/C9MD00169G","article-title":"Prodrug strategies for targeted therapy triggered by reactive oxygen species","volume":"10","author":"Peir\u00f3 Cadah\u00eda","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2026.110488_bb0165","doi-asserted-by":"crossref","first-page":"15611","DOI":"10.1021\/jacs.9b07171","article-title":"Targeting heterogeneous tumors using a multifunctional molecular prodrug","volume":"141","author":"Sharma","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110488_bb0170","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.biomac.9b01578","article-title":"Glutathione and reactive oxygen species dual-responsive block copolymer prodrugs for boosting tumor site-specific drug release and enhanced antitumor efficacy","volume":"21","author":"Yin","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioorg.2026.110488_bb0175","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1039\/C9AN00115H","article-title":"A novel turn-on fluorescent probe for selective sensing and imaging of glutathione in live cells and organisms","volume":"144","author":"Zhang","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.bioorg.2026.110488_bb0180","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1038\/s41375-021-01283-5","article-title":"Small-molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in CML cells overcomes BCR-ABL-independent TKI resistance","volume":"35","author":"Song","year":"2021","journal-title":"Leukemia"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:30:56Z","timestamp":1791261056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S0045206826010242"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110488","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided design of a GSH-activated Hsp70 targeting prodrug with enhanced tumor selectivity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110488"}}